Literature DB >> 16874721

The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance?

August Heidland1, André Klassen, Przemyslaw Rutkowski, Udo Bahner.   

Abstract

At the beginning of the 19th century, medicine was based largely on speculative and philosophical concepts. The greatest merit of Rudolf Virchow was without doubt a way of thinking based on natural science. In place of the empirical chaos represented by the doctrines of humors and crasis, he created the new paradigm of cellular pathology. In the field of inflammation, he critically analyzed the meaning of the four key symptoms of inflammation (redness, swelling, heat and pain) and postulated that inflammation cannot be represented as a single process but rather constitutes various inflammatory processes. In addition he introduced the functio laesa , denoting the restricted function of inflamed tissues. In the pathogenesis of inflammation, Virchow highlighted the importance of the inflammatory stimulus. The irritatio is the starting point and the conditio sine qua non . Through his pathohistological investigations in experimental animals and in humans, inflammation was widely accepted as the central cause of atherosclerosis, until the end of the 19th century, and has been confirmed in recent decades. It was Virchow who first coined the term endarteriitis deformans . Likewise, he was also the first to hypothesize a link between microinflammation and subsequent cancer development. This hypothesis has recently been corroborated by numerous studies and may have therapeutic consequences. Virchow contributed to nearly all aspects of human pathology and championed the cause of social medicine.

Entities:  

Mesh:

Year:  2006        PMID: 16874721

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  25 in total

1.  Thiocolchicoside exhibits anticancer effects through downregulation of NF-κB pathway and its regulated gene products linked to inflammation and cancer.

Authors:  Simone Reuter; Sahdeo Prasad; Kanokkarn Phromnoi; Jayaraj Ravindran; Bokyung Sung; Vivek R Yadav; Ramaswamy Kannappan; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2010-10-26

2.  Inflammation and cancer.

Authors:  Noemí Eiró; Francisco J Vizoso
Journal:  World J Gastrointest Surg       Date:  2012-03-27

Review 3.  Tumor-like coronary atheroma: a modern coronary evaluation with a historical perspective.

Authors:  Brian G Schwartz; Jeffrey M Schussler; Robert L Rosenthal
Journal:  Tex Heart Inst J       Date:  2011

4.  Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Omnia El-Badawy; Mona H Abdel-Rahim; Wageeh A M Ali; Amal Rayan; Muhammad Abbas El-Masry; Mohamed A A Abozaid; Helal F Hetta
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 5.  Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.

Authors:  Sahdeo Prasad; Amit K Tyagi; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-24

Review 6.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

Review 7.  The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases.

Authors:  Ning Ding; Ashley R Maiuri; Heather M O'Hagan
Journal:  Mutat Res Rev Mutat Res       Date:  2017-09-28       Impact factor: 5.657

Review 8.  Chasing the recipe for a pro-regenerative immune system.

Authors:  James W Godwin; Alexander R Pinto; Nadia A Rosenthal
Journal:  Semin Cell Dev Biol       Date:  2016-08-10       Impact factor: 7.727

Review 9.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention.

Authors:  Rita-Marie T McFadden; Claire B Larmonier; Kareem W Shehab; Monica Midura-Kiela; Rajalakshmy Ramalingam; Christy A Harrison; David G Besselsen; John H Chase; J Gregory Caporaso; Christian Jobin; Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.